Blueprint Medicines Corporation (BPMC) Financials

$89.54

north_east
$1.19 (1.35%)
Day's range
$88.63
Day's range
$91

BPMC Income statement / Annual

Last year (2024), Blueprint Medicines Corporation's total revenue was $508.82 M, an increase of 104.04% from the previous year. In 2024, Blueprint Medicines Corporation's net income was -$67.09 M. See Blueprint Medicines Corporation,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Operating Revenue $508.82 M $249.38 M $204.04 M $180.08 M $793.74 M $66.51 M $44.52 M $21.43 M $27.77 M $11.40 M
Cost of Revenue $20.16 M $12.80 M $17.81 M $17.93 M $425,000.00 $0.00 $243.62 M $144.69 M $81.13 M $48.59 M
Gross Profit $488.66 M $236.58 M $186.22 M $162.15 M $793.31 M $66.51 M -$199.10 M -$123.26 M -$53.36 M -$37.19 M
Gross Profit Ratio 0.96 0.95 0.91 0.9 1 1 -4.47 -5.75 -1.92 -3.26
Research and Development Expenses $341.43 M $427.72 M $477.42 M $601.03 M $326.86 M $331.45 M $243.62 M $144.69 M $81.13 M $48.59 M
General & Administrative Expenses $262.67 M $278.24 M $219.27 M $181.79 M $148.34 M $96.39 M $47.93 M $27.99 M $19.22 M $14.46 M
Selling & Marketing Expenses $96.60 M $16.90 M $18.10 M $13.50 M $9.40 M $3.30 M $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $359.27 M $295.14 M $237.37 M $195.29 M $157.74 M $96.39 M $47.93 M $27.99 M $19.22 M $14.46 M
Other Expenses $0.00 $0.00 $8.95 M $7.80 M -$366,000.00 -$100,000.00 $10.46 M $3.35 M $551,000.00 -$429,000.00
Operating Expenses $700.71 M $722.86 M $723.74 M $804.13 M $484.60 M $427.84 M $291.55 M $172.67 M $100.35 M $63.04 M
Cost And Expenses $720.87 M $735.66 M $741.55 M $822.06 M $485.03 M $427.84 M $291.55 M $172.67 M $100.35 M $63.04 M
Interest Income $40.66 M $0.00 $17.75 M $2.39 M $6.60 M $13.73 M $10.64 M $3.43 M $0.00 $0.00
Interest Expense $68.81 M $0.00 $16.77 M $0.00 $0.00 $13.73 M $73,000.00 $221,000.00 $469,000.00 $696,000.00
Depreciation & Amortization $16.29 M $11.67 M $20.10 M $12.79 M $12.35 M $10.25 M $4.25 M $1.58 M $1.58 M $948,000.00
EBITDA -$212.04 M -$470.36 M -$515.42 M -$628.30 M $308.71 M -$356.07 M -$242.78 M -$149.67 M -$70.44 M -$51.13 M
EBITDA Ratio -0.42 -1.89 -2.63 -3.56 0.39 -5.43 -5.31 -6.9 -2.59 -4.57
Operating Income Ratio -0.42 -1.95 -2.69 -3.6 0.38 -5.51 -5.55 -6.98 -2.65 -4.65
Total Other Income/Expenses Net $146.18 M -$19.74 M -$14.76 M $897,000.00 $6.23 M $13.63 M $10.39 M $3.13 M $82,000.00 -$1.13 M
Income Before Tax -$65.86 M -$506.02 M -$552.28 M -$641.08 M $314.94 M -$347.69 M -$236.64 M -$148.12 M -$72.50 M -$52.77 M
Income Before Tax Ratio -0.13 -2.03 -2.71 -3.56 0.4 -5.23 -5.32 -6.91 -2.61 -4.63
Income Tax Expense $1.23 M $968,000.00 $5.24 M $3.00 M $1.06 M -$18.99 M $10.46 M $1.99 M -$562,000.00 -$681,000.00
Net Income -$67.09 M -$506.98 M -$557.52 M -$644.09 M $313.88 M -$328.70 M -$236.64 M -$148.12 M -$72.50 M -$52.77 M
Net Income Ratio -0.13 -2.03 -2.73 -3.58 0.4 -4.94 -5.32 -6.91 -2.61 -4.63
EPS -1.07 -8.37 -9.35 -11.01 5.76 -6.87 -5.39 -3.92 -2.64 -2.89
EPS Diluted -1.07 -8.37 -9.35 -11.01 5.59 -6.87 -5.39 -3.92 -2.64 -2.89
Weighted Average Shares Out $62.86 M $60.56 M $59.64 M $58.52 M $54.53 M $47.83 M $43.87 M $37.79 M $27.49 M $18.24 M
Weighted Average Shares Out Diluted $62.86 M $60.56 M $59.64 M $58.52 M $56.17 M $47.83 M $43.87 M $37.79 M $27.49 M $18.24 M
Link